Dexmethylphenidate Extended Release: In Attention-Deficit Hyperactivity Disorder

By Robinson Dean M.   Keating Gillian M.  

Drugs, Vol. 66, Iss. 5, 2006-01 ,pp. : 661-668

Adis International

Access to resources Recommend Favorite

Effects of Guanfacine Extended Release on Oppositional Symptoms in Children Aged 6-12 Years with Attention-Deficit Hyperactivity Disorder and Oppositional Symptoms: A Randomized, Double-Blind, Placebo-Controlled Trial

By Connor Daniel F.  

CNS Drugs, Vol. 24, Iss. 9, 2010-09 ,pp. : 755-768

Adis International

Access to resources Recommend Favorite

SLI 381 appears suitable for once-daily dosing in paediatric patients with attention-deficit hyperactivity disorder

By  

Inpharma, Vol. 1, Iss. 1393, 2003-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial

By Akhondzadeh S.   Tavakolian R.   Davari-Ashtiani R.   Arabgol F.   Amini H.  

Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 27, Iss. 5, 2003-08 ,pp. : 841-845

Elsevier

Access to resources Recommend Favorite

Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder

By Bilici M.   Yildirim F.   Kandil S.   Bekaroglu M.   Yildirmis S.   Deger O.   Ulgen M.   Yildiran A.   Aksu H.  

Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 28, Iss. 1, 2004-01 ,pp. : 181-190

Elsevier

Access to resources Recommend Favorite